NCT01593085

Brief Summary

The investigators propose a study that aims to develop a methodology for assessing this risk and the psychological consequences of the malignancy in the palliative phase.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 7, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

February 6, 2013

Status Verified

April 1, 2012

Enrollment Period

10 months

First QC Date

April 30, 2012

Last Update Submit

February 5, 2013

Conditions

Keywords

palliative carescancersuicide risk

Outcome Measures

Primary Outcomes (1)

  • assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.

    assessing the prevalence of suicide risk in patients with cancer admitted to a palliative care service.

    at inclusion only, during hospitalization in palliative cares

Secondary Outcomes (3)

  • Evaluate the feasibility of a methodology for estimating the risk of suicide in patients with cancer admitted to a palliative care service

    at inclusion only, during hospitalization in palliative cares

  • Assess the psychological impact of cancer pathology in patients in palliative

    at inclusion only, during hospitalization in palliative cares

  • Identify risk factors for suicide in this patient population

    at inclusion only, during hospitalization in palliative cares

Study Arms (1)

patients in palliative cares

patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)

Behavioral: interview with a doctor for evaluating suicide risk

Interventions

patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk) \--------------------------------------------------------------------------------

patients in palliative cares

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with cancer in palliative cares

You may qualify if:

  • Patient (s) age (s) 18 or more
  • Patient (s) reach (s) of a cancer palliative stage
  • Patient (s) hospital (s) in the palliative care service
  • Patient (s) with cognitive function to an interrogation
  • Patient (s) having a physical condition for an interview lasting 45 minutes
  • Patient (s) that received clear information on the diagnosis and prognosis of their disease.
  • Free and informed consent signed

You may not qualify if:

  • Patient (s) age (s) under 18 years
  • Patient (s) under supervision or unable to give informed consent
  • Patient (s) whose cognitive functions do not allow an examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre François BACLESSE

Caen, Calvados, 14076, France

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as Topic

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Marie-Christine GRACH, MD

    Centre François Baclesse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2012

First Posted

May 7, 2012

Study Start

April 1, 2012

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

February 6, 2013

Record last verified: 2012-04

Locations